ImmuniWeb® Discovery vs RADICL Managed Attack Surface: Side-by-Side Comparison (2026)

ImmuniWeb® Discovery: ImmuniWeb Discovery is an attack surface management platform that continuously monitors an organization's external digital assets for security vulnerabilities, misconfigurations, and threats across domains, applications, cloud resources, and the dark web. built by ImmuniWeb. Core capabilities include Attack Surface Management, Continuous Security Monitoring, Third-Party Risk Monitoring..

RADICL Managed Attack Surface: Managed attack surface platform for vulnerability detection and remediation. built by RADICL. Core capabilities include Real-time vulnerability discovery across endpoints and servers, Risk-prioritized vulnerability remediation, Critical vulnerability escalation with predefined runbooks and SLAs..

Both serve the External Attack Surface Management market but differ in approach, feature depth, and target audience.

ImmuniWeb® Discovery differentiates with Attack Surface Management, Continuous Security Monitoring, Third-Party Risk Monitoring. RADICL Managed Attack Surface differentiates with Real-time vulnerability discovery across endpoints and servers, Risk-prioritized vulnerability remediation, Critical vulnerability escalation with predefined runbooks and SLAs.

ImmuniWeb® Discovery is developed by ImmuniWeb. RADICL Managed Attack Surface is developed by RADICL. Vendor maturity, funding stage, and team size can be important factors when evaluating long-term viability and support quality.

ImmuniWeb® Discovery and RADICL Managed Attack Surface serve similar External Attack Surface Management use cases: both are External Attack Surface Management tools. Review the feature comparison above to determine which fits your requirements.